TickerFactsScreenerDevelopers

SUPERNUS PHARMACEUTICALS, INC. (SUPN) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$40.12M2011: -$37.75M2012: -$42.17M2013: -$61.92M2014: -$5.28M2015: $20.84M2016: $54.22M2017: $99.54M2018: $144.44M2019: $148.57M2020: $173.70M2021: $86.03M2022: $46.12M2023: -$5.27M2024: $81.67M2025: -$62.28M-$62.28M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$62.28M-176.3%
2024$81.67M+1649.9%
2023-$5.27M-111.4%
2022$46.12M-46.4%
2021$86.03M-50.5%
2020$173.70M+16.9%
2019$148.57M+2.9%
2018$144.44M+45.1%
2017$99.54M+83.6%
2016$54.22M+160.1%
2015$20.84M+494.9%
2014-$5.28M+91.5%
2013-$61.92M-46.8%
2012-$42.17M-11.7%
2011-$37.75M+5.9%
2010-$40.12M—